Clinical trial
Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas
NCT00389077 · AEterna Zentaris, Industry · Completed
Key facts
| NCT number | NCT00389077 |
|---|---|
| Title | Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas |
| Official title | A Phase IIA Trial of Two Schedules of Perifosine |
| Lead sponsor | AEterna Zentaris, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Tumors, Lymphomas |
| Intervention type | Drug |
| Interventions | Perifosine |
| Enrollment | 558 |
| Start date | Jan 1, 2005 |
| Primary completion | Jul 1, 2011 |
| Completion | Sep 1, 2011 |
| First posted | Oct 18, 2006 |
| Last update posted | Mar 7, 2018 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: